Varicose Veins
Conditions
Keywords
Varicose Veins, Superficial Thrombophlebitis, Deep Vein Thrombosis, Ulceration, leg pain, leg swelling
Brief summary
The overall objective will be to evaluate clinical predictors of outcomes in patients who undergo endovenous sclerotherapy for the treatment of varicose veins.
Detailed description
A prospective cohort study of patients who undergo endovenous sclerotherapy over 2 years. There are no deviations in usual clinical assessment and care of patients seeking varicose vein treatment. The purpose of this protocol is only to collect clinical and biomarker information related to this standard treatment.
Interventions
None listed
Sponsors
University of Oklahoma
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Clinical diagnosis of varicose veins
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of obliteratin (total or partial) of injected varicosity. | assessment will be at 1, 12, and 26 weeks. |
| Improvement in venous stasis symptoms. | assessment will be at 1, 12, and 26 weeks |
| Change in quality of life. | assessment will be at 1, 12, and 26 weeks |
| Associations between clinical outcomes and biomarkers. | assessment will be at 1, 12, and 26 weeks |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence of varicosities. | assessment will be at 1, 12, and 26 weeks |
| Adverse events reported following procedure. | assessment will be at 1, 12, and 26 weeks |
Countries
United States
Outcome results
None listed